US 7,544,653 B2
	Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
Zlatko Ademovic, Titova 17, 76290 Odzak (Bosnia and Herzegovina); Nikola Stambuk, Subiceva 16, 10 000 Zagreb (Croatia); Pasko Konjevoda, Stjepana Draganica 1, 10 000, Zagreb (Croatia); and Darko Mikus, Kukuljeviceva 10, 21 000, Split (Croatia)
Appl. No. 10/492,908 PCT Filed Nov. 29, 2001, PCT No. PCT/BA01/00005 § 371(c)(1), (2), (4) Date Sep. 10, 2004, PCT Pub. No. WO03/033017, PCT Pub. Date Apr. 24, 2003.
Claims priority of application No. BAP01898A (BA), filed on Oct. 18, 2001.
Prior Publication US 2005/0014696 A1, Jan. 20, 2005
Int. Cl. A61K 38/04 (2006.01)

U.S. Cl. 514—2  [514/14; 514/17]

22 Claims

1. A composition comprising two isolated peptides wherein the first isolated peptide consists of the amino acid sequence of SEQ ID NO: 1 and the second isolated peptide consists of the amino acid sequence of SEQ ID NO: 2, and wherein the composition is suitable for use in humans.